Clinical manifestations in patients with persistent asthma

Authors

  • Alina Márquez Chacón Hospital Provincial Docente Clinicoquirúrgico “Saturnino Lora Torres”, Santiago de Cuba
  • Kanie Collado Llópiz Hospital Provincial Docente Clinicoquirúrgico “Saturnino Lora Torres”, Santiago de Cuba
  • Nelsa Sagaró del Campo Universidad de Ciencias Médicas, Santiago de Cuba
  • Caridad Sánchez Silot Hospital Infantil Sur Universitario “Dr. Antonio Veguez César”, Santiago de Cuba
  • Gladys Aída Estrada Pereira Universidad de Ciencias Médicas, Santiago de Cuba

Keywords:

persistent asthma, nasosinopathy, unspecific irritant, respiratory infection, secondary health care.

Abstract

A descriptive and cross-sectional, cases and controls non paired study of 120 patients with persistent asthma was carried out. They were assisted in the Allergology Service of the Specialties Polyclinic, belonging to "Saturnino Lora Torres"TeachingClinicalSurgicalProvincialHospitalinSantiago de Cuba, from January, 2014 to the same period in 2015, aimed at describing the clinical characteristics and causes of this disease. The patients were selected by means of simple random sampling and they were distributed into 2 groups: one of 60 members with severe asthma (study group) and the other with the same number with light asthma (control group). In the case material there was a prevalence of those affected with moderate-severe persistent asthma from the female sex and the 40 years age group and over, while the unspecific irritant and the respiratory infections were the predisposing factors that occurred with more frequency. The association with nasosinopathies and the abrupt changes of temperature were notable. 

Downloads

Download data is not yet available.

References

1. Negrín Villavicencio J. Asma Bronquial. Aspectos Básicos para un tratamiento integral. 2 ed. La Habana: Ecimed; 2012. p. 94–159.

2. Chile. Ministerio de Salud Pública. Guía clínica asma bronquial del adulto. 2 ed. Santiago de Chile: MINAL; 2013.

3. Murphy VE, Gibson PG. Asthma in pregnancy. Clin Chest Med. 2011; 32(1):93-110.

4. González Ungo ELL, Peña Abraham MM, Romero Díaz C, Valladares Hernández M. Propuesta de estrategia preventiva para el asma bronquial: estudio de gemelos. Rev Ciencias Médicas. 2010 [citado 20 May 2010]; 14(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942010000100021

5. Maldonado de los Reyes B, Alba Carcasés Y, Guillot Monte GE, Naranjo Arroyo M. Caracterización de gestantes con asma bronquial en el barrio “José Félix Ribas” del municipio venezolano de Sucre. MEDISAN. 2012 [citado 10 Dic 2012]; 16(8). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192012000800004

6. Vega Pazitková T, Pérez Martínez VT, Bezos Martínez L. Relación entre la severidad de las manifestaciones de asma bronquial y el cumplimiento del tratamiento intercrisis. Rev Cubana Med Gen Integr. 2011 [citado 20 Mar 2012]; 27(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252011000300001

7. Herrera AB, Rodríguez LA, Niederbacher J. Contaminación biológica intradomiciliaria y su relación con síntomas respiratorios indicativos de asma bronquial en preescolares de Bucaramanga, Colombia. Biomédica. 2011; 31(3):357-71.

8. Pagani JM, Capote Mir R. Sistemas locales de salud; conceptos, métodos, experiencias. Publicaciones Científicas No. 519. Washington, DC: OPS; 1990. p. 445-6.

9. Vega Pazitková T, Pérez Martínez VT, Castillo Iriarte L. Comportamiento clínico-epidemiológico del asma bronquial en menores de 15 años. Rev Cubana Med Gen Integr. 2013; 29(3): 253-66.

10. Boletín de información diaria (UPI). Washington. Octubre 21/2011.

11. Cuba. Ministerio de Salud Pública. Dirección Nacional de registros médicos y estadísticos de salud. Anuario estadístico de Salud 2012. La Habana: MINSAP; 2013. p.97.

12. Aguarón Pérez J, Alonso Lebrero E, Cabrera Navarro P, De Diego Damiá A, Del Cubillo Bernal A, Fernández pascual A, et al. Gema. Guía española para el manejo del asma. Madrid: Editorial Luzán; 2009.

13. Gern JE. The urban environment and childhood asthma study. J Allergy Clin Immunol. 2010; 125(3):545-9.

13. Global iniative for asthma. Global strategy for asthma management and prevention. 2016 [citado 8 Ene 2017]. Disponible en: http://ginasthma.org/wp-content/uploads/2016/04/GINA-2016-main-report_tracked.pdf

14. O’Byrne PM. Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010; 138:1-3.

15. Brannan JD, Lougheed MD. Airway hyperresponsiveness in asthma: mechanisms, clinical significance and treatment. Front Physiol. 2012; 3:460.

16. Busse WW. The relationship of airway hyperresponsiveness and airway inflammation. Chest. 2010; 138:4-10.

17. Muñoz López F. Actualización del concepto de asma. ¿Es el asma un síndrome? Revista Alergia México 2015; 62:134-41.

18. Mallol J, García Marcos L, Solé D, Brand P. International prevalence of recurrent wheezing during the first year of life: variability, treatment patterns and use of health resources. Thorax 2010; 65(11): 1004-9.

19. Arteaga Prado Y, Arencibia Díaz L, Gómez Guerra DB, Martínez Martínez A, Almora Carbonell C. Caracterización epidemiológica de la descompensación aguda del asma bronquial. Rev Ciencias Médicas. 2013; 17(4): 94-104.

Downloads

Published

2017-07-10

How to Cite

1.
Márquez Chacón A, Collado Llópiz K, Sagaró del Campo N, Sánchez Silot C, Estrada Pereira GA. Clinical manifestations in patients with persistent asthma. MEDISAN [Internet]. 2017 Jul. 10 [cited 2025 Jun. 4];21(7). Available from: https://medisan.sld.cu/index.php/san/article/view/1613

Issue

Vol. 21 No. 7 (2017): MEDISAN

Section

Original Articles

License

All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.